Cargando…
Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction.
The usefulness of serum DU-PAN-2 in diagnosing pancreatic cancer and in distinguishing between this cancer and other benign and malignant diseases, and to assess the role of liver dysfunction in altering the serum levels of this marker were investigated. DU-PAN-2 was measured in the sera of 31 patie...
Autores principales: | Fabris, C., Malesci, A., Basso, D., Bonato, C., Del Favero, G., Tacconi, M., Meggiato, T., Fogar, P., Panozzo, M. P., Ferrara, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971859/ https://www.ncbi.nlm.nih.gov/pubmed/2003987 |
Ejemplares similares
-
The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression
por: Basso, Daniela, et al.
Publicado: (2013) -
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
por: Panucci, A., et al.
Publicado: (1985) -
Obstructive Jaundice in Chronic Pancreatitis
por: Hollands, M. J., et al.
Publicado: (1989) -
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
por: Tonack, S, et al.
Publicado: (2013) -
Chionanthus in Jaundice
por: Morrow, H. C.
Publicado: (1896)